Valion Bio, Inc. (VBIO)
1.17
-0.06
(-4.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
Valion Bio Net Income (Quarterly) : -7.057M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.057M |
| March 31, 2026 | -6.225M |
| September 30, 2025 | -2.596M |
| June 30, 2025 | -1.675M |
| March 31, 2025 | -1.373M |
| December 31, 2024 | -1.477M |
| September 30, 2024 | -1.431M |
| June 30, 2024 | -1.266M |
| March 31, 2024 | -1.481M |
| December 31, 2023 | -2.243M |
| September 30, 2023 | -1.76M |
| June 30, 2023 | -2.125M |
| March 31, 2023 | -2.116M |
| Date | Value |
|---|---|
| December 31, 2022 | -2.254M |
| September 30, 2022 | -2.584M |
| June 30, 2022 | -3.018M |
| March 31, 2022 | -2.24M |
| December 31, 2021 | -3.724M |
| September 30, 2021 | -2.32M |
| June 30, 2021 | -1.094M |
| March 31, 2021 | -1.356M |
| December 31, 2020 | -1.117M |
| September 30, 2020 | -0.935M |
| June 30, 2020 | -0.585M |
| March 31, 2020 | -1.002M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Outlook Therapeutics, Inc. | -20.32M |
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.057M |
| EPS Diluted (Quarterly) | -52.54 |
| Enterprise Value | 23.13M |
| Earnings Yield | -17.97K% |
| Normalized Earnings Yield | -18005.50 |